Author:
Laguna Egea Juan Carlos,Roglans Ribas Núria,Bentanachs Raset Roger
Reference14 articles.
1. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society;Ginsberg;Eur Heart J,2021
2. Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease;Ganda;Curr Opin Lipidol,2023
3. Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis;Pintó;Clín Investig Arterioscler,2023
4. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials;Ridker;Lancet,2023
5. Peroxisome proliferator-activated receptors and the control of inflammation;Cabrero;Curr Drug Targets Inflamm Allergy,2002